Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
Polyzos SA, Kountouras J, Anastasilakis AD, Makras P, Hawa G, Sonnleitner L, Missbichler A, Doulberis M, Katsinelos P, Terpos E. Polyzos SA, et al. Among authors: katsinelos p. Hormones (Athens). 2018 Dec;17(4):573-579. doi: 10.1007/s42000-018-0083-8. Epub 2018 Nov 22. Hormones (Athens). 2018. PMID: 30467685 Clinical Trial.
Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.
Polyzos SA, Kountouras J, Mantzoros CS, Polymerou V, Katsinelos P. Polyzos SA, et al. Among authors: katsinelos p. Diabetes Obes Metab. 2017 Dec;19(12):1805-1809. doi: 10.1111/dom.12989. Epub 2017 Jul 10. Diabetes Obes Metab. 2017. PMID: 28452101 Clinical Trial.
Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.
Polyzos SA, Kountouras J, Mavrouli M, Katsinelos P, Doulberis M, Gavana E, Duntas L. Polyzos SA, et al. Among authors: katsinelos p. Exp Clin Endocrinol Diabetes. 2019 Oct;127(9):598-602. doi: 10.1055/a-0811-9136. Epub 2019 Jan 9. Exp Clin Endocrinol Diabetes. 2019. PMID: 30625508 Clinical Trial.
Helicobacter pylori might contribute to nonalcoholic fatty liver disease-related cardiovascular events by releasing prothrombotic and proinflammatory factors.
Kountouras J, Polyzos SA, Zavos C, Deretzi G, Kountouras C, Vardaka E, Katsinelos P, Tsiaousi E, Grigoriadis N, Romiopoulos I, Tzilves D, Giartza-Taxidou E. Kountouras J, et al. Among authors: katsinelos p. Hepatology. 2014 Oct;60(4):1450-1. doi: 10.1002/hep.27168. Epub 2014 May 19. Hepatology. 2014. PMID: 24723444 No abstract available.
304 results